Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback